BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15979831)

  • 1. New frontiers in proteomics research: a perspective.
    Dhingra V; Gupta M; Andacht T; Fu ZF
    Int J Pharm; 2005 Aug; 299(1-2):1-18. PubMed ID: 15979831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in computational inference from mass spectrometry-based proteomics.
    Webb-Robertson BJ; Cannon WR
    Brief Bioinform; 2007 Sep; 8(5):304-17. PubMed ID: 17584764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic methods to exploit mass spectrometric data for proteomic applications.
    Chalkley RJ; Hansen KC; Baldwin MA
    Methods Enzymol; 2005; 402():289-312. PubMed ID: 16401513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
    Faber MJ; Agnetti G; Bezstarosti K; Lankhuizen IM; Dalinghaus M; Guarnieri C; Caldarera CM; Helbing WA; Lamers JM
    Cell Biochem Biophys; 2006; 44(1):11-29. PubMed ID: 16456231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical proteomics: two-dimensional electrophoresis/MALDI mass spectrometry.
    Zimny-Arndt U; Schmid M; Ackermann R; Jungblut PR
    Methods Mol Biol; 2009; 492():65-91. PubMed ID: 19241027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informatics development: challenges and solutions for MALDI mass spectrometry.
    Fenyö D; Beavis RC
    Mass Spectrom Rev; 2008; 27(1):1-19. PubMed ID: 17979143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput proteomics using matrix-assisted laser desorption/ ionization mass spectrometry.
    Cramer R; Gobom J; Nordhoff E
    Expert Rev Proteomics; 2005 Jun; 2(3):407-20. PubMed ID: 16000086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene arrays and proteomics. A primer.
    Moulédous L; Gutstein HB
    Methods Mol Med; 2003; 84():141-54. PubMed ID: 12703322
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics in reproductive medicine: the technology for separation and identification of proteins.
    Hachey DL; Chaurand P
    J Reprod Immunol; 2004 Aug; 63(1):61-73. PubMed ID: 15284006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics: from gel based to gel free.
    Lambert JP; Ethier M; Smith JC; Figeys D
    Anal Chem; 2005 Jun; 77(12):3771-87. PubMed ID: 15952756
    [No Abstract]   [Full Text] [Related]  

  • 13. Technology insight: the application of proteomics in gastrointestinal disease.
    Din S; Lennon AM; Arnott ID; Hupp T; Satsangi J
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):372-85. PubMed ID: 17607293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
    Engwegen JY; Gast MC; Schellens JH; Beijnen JH
    Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of 2-D gels to identify novel protein-protein interactions in the cochlea.
    Kathiresan T; Harvey MC; Sokolowski BH
    Methods Mol Biol; 2009; 493():269-86. PubMed ID: 18839353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics: the basic overview.
    Figeys D
    Methods Biochem Anal; 2005; 45():1-62. PubMed ID: 19235290
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomic analysis of the mammalian cell nucleus.
    Tewari AK; Roy S; Khanna S; Sen CK
    Methods Enzymol; 2004; 381():192-201. PubMed ID: 15063675
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomic analysis in cardiovascular diseases.
    Cieniewski-Bernard C; Acosta A; Dubois E; Lamblin N; Beseme O; Chwastyniak M; Amouyel P; Bauters C; Pinet F
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):362-6. PubMed ID: 18307721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteomic analysis and parasitosis: principles and applications].
    Almeras L; Briolant S; Orlandi-Pradines E; Fontaine A; Henry M; Bogreau H; Pradines B; Rogier C; Fusai T
    Med Trop (Mars); 2007 Apr; 67(2):188-96. PubMed ID: 17691442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.